{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:00:19Z","timestamp":1777654819102,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009510","name":"University of Hull","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["44242"],"award-info":[{"award-number":["44242"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["61479"],"award-info":[{"award-number":["61479"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.bone.2021.116285","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T02:36:55Z","timestamp":1639103815000},"page":"116285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Genetic risk for the polycystic ovary syndrome, bone mineral density and fractures in women and men: A UK Biobank Mendelian randomisation study"],"prefix":"10.1016","volume":"155","author":[{"given":"Harshal","family":"Deshmukh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najeeb","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Altigani","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadel","family":"Lhaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mo","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thozhukat","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2021.116285_bb0005","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820938305","article-title":"A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome","volume":"11","author":"Abdalla","year":"2020","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2021.116285_bb0010","doi-asserted-by":"crossref","DOI":"10.1177\/2042018821989238","article-title":"The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence","volume":"12","author":"Abdalla","year":"2021","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.bone.2021.116285_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2021.116285_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034733","article-title":"Improving reproductive function in women with polycystic ovary syndrome with high-intensity interval training (IMPROV-IT): study protocol for a two-centre, three-armed randomised controlled trial","volume":"10","author":"Kiel","year":"2020","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.bone.2021.116285_bb0025","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1210\/jcem.85.10.6902","article-title":"Clinical review 116: bone mineral density, androgens, and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone","volume":"85","author":"Zborowski","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bone.2021.116285_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0015-0282(99)00203-4","article-title":"Bone mineral density and body composition in lean women with polycystic ovary syndrome","volume":"72","author":"Good","year":"1999","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.bone.2021.116285_bb0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0889-8545(05)70190-X","article-title":"Polycystic ovary syndrome, androgen excess, and the impact on bone","volume":"28","author":"Zborowski","year":"2001","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"issue":"8","key":"10.1016\/j.bone.2021.116285_bb0040","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/humrep\/deq149","article-title":"Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study","volume":"25","author":"Kassanos","year":"2010","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.bone.2021.116285_bb0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jbmr.2737","article-title":"Fracture risk is decreased in women with polycystic ovary syndrome: a register-based and population-based cohort study","volume":"31","author":"Rubin","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2021.116285_bb0050","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1249\/MSS.0b013e318195a21a","article-title":"Hyperandrogenism may explain reproductive dysfunction in olympic athletes","volume":"41","author":"Hagmar","year":"2009","journal-title":"Med. Sci. Sports Exerc."},{"issue":"12","key":"10.1016\/j.bone.2021.116285_bb0055","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40618-014-0175-5","article-title":"Bone mineral density in women with polycystic ovary syndrome","volume":"37","author":"Katulski","year":"2014","journal-title":"J. Endocrinol. Investig."},{"issue":"10","key":"10.1016\/j.bone.2021.116285_bb0060","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1055\/a-0733-7768","article-title":"Bone mineral density is unaltered in women with polycystic ovary syndrome","volume":"50","author":"Ganie","year":"2018","journal-title":"Horm. Metab. Res."},{"issue":"5","key":"10.1016\/j.bone.2021.116285_bb0065","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/humupd\/dmz020","article-title":"Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis","volume":"25","author":"Piovezan","year":"2019","journal-title":"Hum. Reprod. Update"},{"issue":"3","key":"10.1016\/j.bone.2021.116285_bb0070","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.mehy.2006.03.057","article-title":"Polycystic ovary syndrome in men: stein-leventhal syndrome revisited","volume":"68","author":"Kurzrock","year":"2007","journal-title":"Med. Hypotheses"},{"issue":"Suppl 1","key":"10.1016\/j.bone.2021.116285_bb0075","doi-asserted-by":"crossref","first-page":"A773","DOI":"10.1210\/jendso\/bvab048.1574","article-title":"A genetically defined male counterpart of polycystic ovary syndrome: evidence for ovarian-independent pathogenesis","volume":"5","author":"Zhu","year":"2021","journal-title":"J. Endocr. Soc."},{"issue":"R1","key":"10.1016\/j.bone.2021.116285_bb0080","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"19","key":"10.1016\/j.bone.2021.116285_bb0085","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.bone.2021.116285_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PLoS Genet."},{"issue":"2","key":"10.1016\/j.bone.2021.116285_bb0095","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.bone.2021.116285_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.fertnstert.2016.05.010","article-title":"Evolutionary determinants of polycystic ovary syndrome: part 1","volume":"106","author":"Unluturk","year":"2016","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.bone.2021.116285_bb0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.fertnstert.2016.05.016","article-title":"Evolutionary determinants of polycystic ovary syndrome: part 2","volume":"106","author":"Fessler","year":"2016","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.bone.2021.116285_bb0110","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.fertnstert.2010.09.032","article-title":"Polycystic ovary syndrome: an ancient disorder?","volume":"95","author":"Azziz","year":"2011","journal-title":"Fertil. Steril."},{"issue":"1)","key":"10.1016\/j.bone.2021.116285_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.bone.2021.116285_bb0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2265.2012.04378.x","article-title":"Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study","volume":"77","author":"Schmidt","year":"2012","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2021.116285_bb0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.steroids.2008.10.003","article-title":"Androgens and bone","volume":"74","author":"Clarke","year":"2009","journal-title":"Steroids"},{"issue":"6","key":"10.1016\/j.bone.2021.116285_bb0130","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jbmr.5650030613","article-title":"Determinants of peak trabecular bone density in women: the role of androgens, estrogen, and exercise","volume":"3","author":"Buchanan","year":"1988","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116285_bb0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1055\/s-2007-1000771","article-title":"Antiandrogen treatment with spironolactone and linestrenol decreases bone mineral density in eumenorrhoeic women with androgen excess","volume":"26","author":"Prezelj","year":"1994","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"10.1016\/j.bone.2021.116285_bb0140","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1172\/JCI118382","article-title":"Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women","volume":"97","author":"Slemenda","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bone.2021.116285_bb0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.33549\/physiolres.930573","article-title":"What may be the markers of the male equivalent of polycystic ovary syndrome?","volume":"53","author":"Duskova","year":"2004","journal-title":"Physiol. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221004518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328221004518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:58:52Z","timestamp":1757613532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328221004518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":29,"alternative-id":["S8756328221004518"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2021.116285","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic risk for the polycystic ovary syndrome, bone mineral density and fractures in women and men: A UK Biobank Mendelian randomisation study","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2021.116285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116285"}}